Evidence map›Paper›PMID 36290685›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters: A Randomized, Double-Blind, Cross-Over, Controlled Trial.

Marta Farràs, Jonathan Richard Swann, Ian Rowland, Laura Rubió, Isaac Subirana, Úrsula Catalán, Maria José Motilva, Rosa Solà, Maria Isabel Covas, Francisco Blanco-Vaca and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Marta FarràsUnit of Nutrition and Cancer, Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Jonathan Richard SwannSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Ian RowlandHugh Sinclair Human Nutrition Group, University of Reading, Reading RG6 6DH, UK.
Laura RubióAntioxidants Research Group, Food Technology Department, AGROTECNIO-CERCA Center, University of Lleida, Avda/Alcalde Rovira Roure 191, 25198 Lleida, Spain.
Isaac SubiranaCIBER de Enfermedades Cardiovasculares (CIBERCV), C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
Úrsula CatalánFunctional Nutrition, Oxidation, and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Hospital Universitari Sant Joan, Universitat Rovira i Virgili, C/Sant Llorenç 21, 43201 Reus, Spain.
Maria José MotilvaAntioxidants Research Group, Food Technology Department, AGROTECNIO-CERCA Center, University of Lleida, Avda/Alcalde Rovira Roure 191, 25198 Lleida, Spain.ORCID 0000-0001-8985-7737
Rosa SolàFunctional Nutrition, Oxidation, and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Hospital Universitari Sant Joan, Universitat Rovira i Virgili, C/Sant Llorenç 21, 43201 Reus, Spain.
Maria Isabel CovasNuProas Handesbolag (NUPROAS HB), 13141 Nacka, Sweden.
Francisco Blanco-VacaCIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), C/Monforte de Lemos 3-5, 28029 Madrid, Spain.ORCID 0000-0001-7380-5385
Montserrat FitóCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Jordi Mayneris-PerxachsCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-3788-3815
Hospital Universitari Sant Joan de Reus · ESInstituto de Salud Carlos III · ESUniversitat de Lleida · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversitat Autònoma de Barcelona · ESUniversity of Reading · GBUniversity of Southampton · GB

Funding

Instituto de Salud Carlos III CD17/00233Instituto de Salud Carlos III CIBERCV, CIBERDEM, and CIBEROBNInstituto de Salud Carlos III CIBEROBN-stay fellowshipInstituto de Salud Carlos III CP18/00009Instituto de Salud Carlos III PI1800164Instituto de Salud Carlos III PI20/01090Spanish Ministry of Science and Innovation (MICINN) AGL2009-13517-C03-01, AGL2009-13517-C03-02, AGL2009-13517-C03-03, and AGL2012-40144-C03-01
6 · The paper itself

Abstract

Phenol-rich foods consumption such as virgin olive oil (VOO) has been shown to have beneficial effects on cardiovascular diseases. The broader biochemical impact of VOO and phenol-enriched OOs remains, however, unclear. A randomized, double-blind, cross-over, controlled trial was performed with thirty-three hypercholesterolemic individuals who ingested for 3-weeks (25 mL/day): (1) an OO enriched with its own olive oil phenolic compounds (PCs) (500 ppm; FOO); (2) an OO enriched with its own olive oil PCs (250 ppm) plus thyme PCs (250 ppm; FOOT); and (3) a VOO with low phenolic content (80 ppm). Serum lipid and glycemic profiles, serum

Indexed as

cardiovascular diseasesfunctional olive oilmetabonomicsphenolic compounds

Identifiers

PMID36290685
PMCPMC9598678
OpenAlexW4303579199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.